Compare VPV & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VPV | STXS |
|---|---|---|
| Founded | 1993 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 183.2M | 210.0M |
| IPO Year | N/A | 2004 |
| Metric | VPV | STXS |
|---|---|---|
| Price | $10.41 | $2.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 36.6K | ★ 471.8K |
| Earning Date | 01-01-0001 | 11-11-2025 |
| Dividend Yield | ★ 3.60% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $30,075,000.00 |
| Revenue This Year | N/A | $24.48 |
| Revenue Next Year | N/A | $29.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 19.62 |
| 52 Week Low | $8.58 | $1.54 |
| 52 Week High | $10.28 | $3.59 |
| Indicator | VPV | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 39.64 | 43.19 |
| Support Level | $10.36 | $2.34 |
| Resistance Level | $10.51 | $2.44 |
| Average True Range (ATR) | 0.10 | 0.10 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 19.05 | 46.55 |
Invesco Pennsylvania Value Municipal Income Trust is a diversified, closed-end management investment company. The investment objective is to provide common shareholders with a high level of current income exempt from federal and Pennsylvania income taxes and, where possible under local law, local income and personal property taxes, consistent with preservation of capital.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.